<DOC>
	<DOCNO>NCT02817100</DOCNO>
	<brief_summary>This study first human study investigate safety , tolerability pharmacokinetics ascend single dos BAY1817080 use placebo control , randomize , single center design . In addition influence itraconazole food pharmacokinetics BAY1817080 investigate .</brief_summary>
	<brief_title>First Human Study Investigate Safety Tolerability , Pharmacokinetics , Itraconazole Drug-drug-interaction Food Effect BAY1817080</brief_title>
	<detailed_description />
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<criteria>Healthy male subject Age : 18 45 year ( inclusive ) Body mass index ( BMI ) : ≥18 ≤30 kg/m² Race : White Any find medical examination ( include blood pressure , pulse rate ECG ) deviate normal clinical relevance Relevant diseases within last 4 week prior first drug administration Existing chronic disease require medication Known suspect malignant tumor carcinoma situ ( include history malignant tumor , status treatment ) , know suspected benign tumor liver pituitary ( include treatment ) Incompletely cure preexisting disease assume absorption , distribution , metabolism , elimination effect study drug normal Use drug might influence result trial within 14 day prior administration trial followup include drug might affect pharmacokinetics</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>